Results 141 to 150 of about 18,063 (229)

Autocatalytic Reaction between HCN and Cysteamine Produces Hydrophobic, Catalytic, Liquid Compartments. [PDF]

J Am Chem Soc
Novichkov AI, Diskin-Posner Y, Shimon LJW, Leitus G, Flamm C, Semenov SN.   +5 more
europepmc   +1 more source

Improving Lifelong Comprehensive Care Coordination in Nephropathic Cystinosis: Multidisciplinary Perspectives. [PDF]

Kidney Int Rep
Golestaneh L, Ames EG, Doyle MH, Ghossein C, Grimm PC, Hewlett JL, Lim A, Marzinelli LS, Schmidt KJ, Smeryage B, Zaritsky JJ, Kaskel FJ.   +11 more
europepmc   +1 more source

Local Guidance on the Management of Nephropathic Cystinosis in the Gulf Cooperation Council (GCC) Region. [PDF]

Children (Basel)
Aleid H, AlShareef T, Kaddourah A, Zeinelabdin M, Alkadi MM, Al Ghaithi B, Abdelkawy Y, Al Khasawneh E, Levtchenko E, Alhasan K.   +9 more
europepmc   +1 more source

Enhanced sensitivity of lateral flow assay for NGAL detection using cysteamine-modified gold nanoparticles. [PDF]

RSC Adv
Tunakhun P, Ngernpimai S, Tippayawat P, Choowongkomon K, Anutrakulchai S, Charoensri N, Tavichakorntrakool R, Daduang S, Srichaiyapol O, Maraming P, Prompipak J, Boonsiri P, Daduang J.   +12 more
europepmc   +1 more source

Autonomous Spatiotemporal Regulation of Reversible Hydrogel Actuators by Chemical Reaction Networks. [PDF]

Adv Mater
Liao F, George A, Sui XM, Semenov SN.
europepmc   +1 more source

Characterisation of Prussian blue modified screen-printed electrodes for thiol detection [PDF]

, 2004
Amine, A, Arduini, F, Moscone, D, Palleschi, G, Ricci, F   +4 more
core   +1 more source

Efficacy of pharmacotherapies on pediatric patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis. [PDF]

BMC Gastroenterol
Yaser S, Yaser H, Mohammed HE, Nasser M, Darwish MK, Haseeb ME, Heiba AH, Ghonaim MM, Aboeldahab H, Bady Z.   +9 more
europepmc   +1 more source

Lysosomal reduced thiols are essential for mouse embryonic development. [PDF]

Proc Natl Acad Sci U S A
Adelmann CH, Venkatachalam A, Huang L, Liu M, Germana S, Harry SA, Rosen PC, Herron J, Tien PC, Bar-Peled L, Sabatini DM, Fisher DE.   +11 more
europepmc   +1 more source

From Molecular Understanding and Pathophysiology to Disease Management; A Practical Approach and Guidance to the Management of the Ocular Manifestations of Cystinosis. [PDF]

Int J Mol Sci
Liang H, Baudouin C, Dupas B, Delcroix T, Giordano V.   +4 more
europepmc   +1 more source

Cystadrops^® Eye Drops for the Management of Ocular Cystinosis in Patients Aged 6 Months to < 2 Years. [PDF]

Ophthalmol Ther
Biswas S, Casteels I, Bremond-Gignac D, Hogan J, Iarossi G.   +4 more
europepmc   +1 more source